Maze Therapeutics aims to raise $100 million in an IPO to fund clinical trials for its kidney and related disease treatments.

Check out the Maze Mice reveal teaser trailer for this upcoming time-freezing, mazerunning bullet heaven roguelite game from ...

Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised ...

Eagan’s Minnesota Ice Festival is now home to the world's largest ice maze, according to the Guinness World Records ...

During a ceremony on Friday at TCO Stadium, the festival's 18,148.89-square-foot ice maze with eight-foot-tall walls was ...

Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...